Grifols (GRFS) Other Operating Expenses (2010 - 2020)

Grifols (GRFS) reported Other Operating Expenses of -$74.9 million for Q1 2020, down 5.28% on a YoY basis from -$79.1 million in Q2 2019, and up 66.32% quarter-over-quarter from -$222.5 million in Q4 2019.

Grifols (GRFS) Other Operating Expenses (2010 - 2020) Analysis & Trends

Grifols has reported Other Operating Expenses for 9 years, with the latest figure at -$74.9 million in Q1 2020.

  • For the quarter ending Q1 2020, Other Operating Expenses fell 5.28% year-over-year to -$74.9 million; the trailing twelve-month figure through Dec 2021 stood at -$74.9 million (up 74.81% YoY), and the FY2025 full-year result was -$0.0, changed N/A from the prior year.
  • Other Operating Expenses for Q1 2020 stood at -$74.9 million, up from -$222.5 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $0.0 in Q3 2016, with the low at -$222.5 million in Q4 2019.
  • Historically, Other Operating Expenses has averaged -$100.7 million across 5 years, with a median of -$71.2 million in 2019.
  • Annual changes were most pronounced in 2017 — Other Operating Expenses tumbled 8.982359418921494e+16% — and 2018, when it grew 9.14%.
  • Grifols' Other Operating Expenses stood at -$0.0 in 2016, then plunged by 8.982359418921494e+16% to -$214.2 million in 2017, then advanced by 9.14% to -$194.6 million in 2018, then slipped by 14.33% to -$222.5 million in 2019, then surged by 66.32% to -$74.9 million in 2020.
  • The last three Other Operating Expenses figures came in at -$74.9 million (Q1 2020), -$222.5 million (Q4 2019), and -$71.2 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols 6.05 Bn 5.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2020 -74.92 Mn
Dec 31, 2019 -222.47 Mn
Mar 31, 2019 -71.16 Mn
Dec 31, 2018 -194.59 Mn
Mar 31, 2018 -66.30 Mn
Dec 31, 2017 -214.16 Mn
Mar 31, 2017 -63.04 Mn
Dec 31, 2016 0.00
Sep 30, 2016 0.00
Dec 31, 2015 1.04 Bn
Jun 30, 2015 0.00
Mar 31, 2015 0.00
Jun 30, 2012 1.01 Mn
Mar 31, 2012 135,065.50
Sep 30, 2011 10.72 Mn
Jun 30, 2011 -430,948.46
Mar 31, 2011 422,558.32
Sep 30, 2010 570,742.50